Berlex Oncology Foundation Bergenfield, NJ - 07621

Berlex Oncology Foundation is categorized under Noncommercial Research Organizations in Bergenfield, NJ and active since 1992.

Berlex Oncology Foundation was established in 1992, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Svetlana Lisanti at the company’s single location by writing to 80 Madison Avenue, Bergenfield, New Jersey NJ 07621 or by phoning (201) 385-0006. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Berlex Oncology Foundation
Contact Person: Svetlana Lisanti
Address: 80 Madison Avenue, Bergenfield, New Jersey 07621
Phone Number: (201) 385-0006
Annual Revenue (USD): $500.000 to $999.999
Founded: 1992
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Berlex Oncology Foundation was started in 1992 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Svetlana Lisanti for inquiries that concern Berlex Oncology Foundation by calling the company number (201) 385-0006, as your correspondence is most welcome. Additionally, the physical location of the single location of Berlex Oncology Foundation can be found at the coordinates as well as the street address 80 Madison Avenue in Bergenfield, New Jersey 07621.

For its online presence, you may visit Berlex Oncology Foundation’s website at and engage with its social media outlets through on Twitter and on Facebook.